Nov 17 (Reuters) - DeCODE Genetics Inc (DCGN), a Reykjavik, Iceland-headquartered bio-pharmaceutical company filed for Chapter 11 bankruptcy protection, court documents showed.
In a filing with the U.S. Bankruptcy Court for the District of Delaware late on Monday, deCODE listed estimated total assets in the range of $50 million to $100 million and estimated total liabilities in the range of $100 million to $500 million.‹
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.